Since the death of ADAR2-deficient motor neurons in AR2 mice is specifically mediated by Ca2+-permeable AMPA receptors, AMPA receptor antagonists are promising candidates to treat ALS. This evidence concerns the gene ADARB1 and amyotrophic lateral sclerosis.